background
serum
cytokin
level
among
mechan
ventil
intens
care
unit
icu
treat
sever
communityacquir
pneumonia
scap
patient
known
microbi
etiolog
three
differ
etiolog
group
assess
method
blood
sampl
creactiv
protein
crp
procalcitonin
pct
interleukin
il
human
interferon
gamma
induc
protein
ip
tumor
necrosi
factor
alpha
collect
time
point
h
studi
inclus
result
pure
bacteri
infect
bacteri
group
bg
pure
viral
infect
viral
group
vg
mix
bacterialvir
infect
mix
group
mg
among
mechan
ventil
scap
patient
crp
pct
level
significantli
higher
mg
valu
decreas
time
group
pct
differ
also
time
group
analysi
p
highest
mg
level
significantli
higher
vg
compar
other
p
time
p
group
p
timexgroup
level
decreas
time
p
time
p
time
differ
group
conclus
scap
patient
viral
etiolog
higher
level
patient
mix
viral
bacteri
group
higher
pct
compar
etiolog
streptococcu
pneumonia
main
caus
pathogen
communityacquir
pneumonia
cap
intens
care
unit
icu
treat
sever
communityacquir
pneumonia
scap
howev
concomit
viral
infect
occur
scap
case
mix
infect
relat
higher
inflammatori
diseas
repres
relev
risk
hospit
icu
treatment
elev
serum
proinflammatori
cytokin
use
prognost
assess
marker
sever
infect
pneumonia
suggest
magnitud
cytokin
secret
vari
depend
caus
microorgan
involv
pneumococc
pneumonia
higher
receptor
antagonist
concentr
found
compar
patient
nonpneumococc
etiolog
cap
patient
gramneg
etiolog
enterobacteriacea
shown
higher
klebsiella
pneumonia
higher
level
compar
etiolog
influenza
pneumonia
transform
growth
factor
tgf
shown
elev
acut
phase
diseas
children
respiratori
syncyti
viru
rsv
pneumonia
present
high
serum
level
interferon
gamma
howev
precis
role
cytokin
relationship
serum
cytokin
level
microbiolog
etiolog
among
mechan
ventil
scap
patient
unclear
purpos
prospect
studi
focu
analyz
cytokin
kinet
first
h
icu
admiss
among
scap
patient
differ
etiolog
pneumonia
use
crp
pct
studi
popul
consist
cohort
scap
patient
admit
mix
icu
tertiari
referr
univers
hospit
june
may
first
part
studi
report
scap
etiolog
publish
earlier
date
sever
cap
defin
acut
lower
respiratori
tract
infect
fever
hypothermia
cough
dyspnea
acquir
outsid
hospit
presenc
pneumonia
confirm
chest
radiograph
demonstr
new
pulmonari
infiltr
patient
fulfil
criteria
sepsi
well
infecti
diseas
societi
america
american
thorac
societi
idasat
major
criteria
scap
adult
patient
older
year
scap
expect
requir
intens
care
treatment
h
start
mechan
ventil
first
h
follow
icu
admiss
includ
studi
hospit
ethic
committe
approv
studi
protocol
written
inform
consent
request
patient
next
kin
detail
descript
method
well
microbiolog
analysi
studi
sampl
defin
pneumonia
etiolog
classif
scap
patient
publish
earlier
studi
follow
data
analyz
age
sex
presenc
preexist
comorbid
chronic
pulmonari
diseas
smoke
serum
creactiv
protein
crp
proclacitonin
pct
siemen
centaur
xp
advia
centaur
brahm
pct
level
record
daili
sum
pulmonari
sever
index
psi
confusionurearespiratori
rateblood
pressur
score
also
report
scap
patient
classifi
three
differ
group
accord
microbi
etiolog
bacteri
group
bg
etiolog
examin
reveal
bacteria
viral
group
vg
viral
find
recov
mix
group
mg
etiolog
examin
yield
bacteri
viral
find
serum
cytokin
detect
blood
sampl
collect
togeth
crp
pct
sampl
time
point
h
studi
inclus
serum
sampl
kept
analyz
viru
diagnost
laboratori
univers
turku
serum
cytokin
level
determin
immunoassay
eotaxin
fgf
basic
gcsf
gmcsf
plateletderiv
growth
factor
rant
vascular
endotheli
growth
factor
vegf
biorad
laboratori
inc
california
unit
state
accord
manufactur
instruct
except
amount
bead
detect
antibodi
streptavidinphycoerythrin
conjug
use
recommend
concentr
test
previous
appropri
analysi
system
result
analyz
bioplex
manag
softwar
statist
analys
calcul
geometr
mean
cytokin
level
sampl
detect
limit
given
valu
detect
limit
divid
two
done
order
enabl
inclus
neg
valu
valu
geometr
mean
calcul
summari
measur
present
median
percentil
unless
state
otherwis
baselin
comparison
three
studi
group
continu
variabl
perform
analysi
varianc
brownforsyth
test
homogen
varianc
test
reject
homogen
assumpt
categor
data
analyz
use
fisher
exact
test
linear
mix
model
lmm
use
repeatedli
measur
data
pvalu
report
lmm
p
time
chang
time
p
group
averag
group
differ
p
time
group
interact
time
group
twotail
pvalu
consid
statist
signific
nonparametr
spearman
correl
coeffici
rho
calcul
analys
perform
use
spss
window
ibm
corp
releas
ibm
spss
statist
window
version
armonk
ny
ibm
corp
sa
version
sa
institut
inc
cari
nc
usa
microbi
etiolog
ventil
scap
patient
identifi
follow
bacteri
etiolog
bacteri
group
bg
diagnos
patient
combin
bacterialvir
etiolog
mix
group
mg
viral
etiolog
viral
group
vg
patient
caus
microb
present
tabl
median
age
three
group
follow
bg
percentil
mg
vg
p
year
male
bg
mg
vg
respect
fifteen
patient
bg
mg
vg
chronic
comorbid
one
patient
vg
chronic
obstruct
pulmonari
diseas
correspond
figur
bg
mg
respect
smoke
common
vg
patient
smoker
bg
mg
smoker
group
patient
bg
mg
vg
treat
corticosteroid
due
septic
shock
icu
stay
accord
immunoassay
result
show
signific
chang
time
group
cytokin
show
highest
valu
first
h
enrol
studi
serum
cytokin
level
admiss
shown
tabl
serum
level
highest
viral
group
p
time
p
group
p
timexgroup
fig
level
decreas
studi
period
p
time
p
time
differ
group
fig
signific
differ
group
fig
median
time
start
mechan
ventil
first
studi
sampl
collect
h
statist
signific
correl
found
cytokin
level
time
gap
spearman
correl
coeffici
calcul
follow
rho
p
rho
p
rho
p
rho
p
respect
median
time
onset
symptom
first
studi
sampl
day
statist
signific
correl
found
cytokin
level
time
gap
onset
symptom
rho
p
rho
p
rho
p
rho
p
crp
pct
level
significantli
higher
mg
valu
decreas
accord
time
group
fig
pct
differ
also
time
group
analysi
p
highest
mg
fig
prospect
studi
consist
sever
ill
patient
requir
mechan
ventil
fulfil
major
criteria
sever
communityacquir
pneumonia
found
patient
viral
group
show
highest
serum
level
first
h
icu
compar
patient
bacteri
mix
viral
mix
group
show
highest
pct
valu
compar
patient
bacteri
viral
etiolog
result
show
scap
patient
viral
etiolog
highest
serum
concentr
previous
shown
children
laboratori
confirm
influenza
viru
pneumonia
higher
concentr
compar
children
without
lower
respiratori
tract
infect
influenza
viru
pneumonia
serum
level
even
higher
among
patient
requir
mechan
ventil
influenza
patient
without
viral
pneumonia
adult
studi
popul
one
pneumon
patient
influenza
viral
infect
pneumonia
due
adeno
corona
rhinoviru
infect
studi
suggest
high
concentr
may
also
relat
viral
pneumonia
support
fact
children
elev
serum
level
also
found
wheez
caus
rhinoviru
respiratori
syncyti
viru
infect
togeth
act
gener
marker
inflamm
pneumonia
regul
express
acut
phase
protein
studi
serum
level
decreas
time
group
gener
high
concentr
serum
bronchoalveolar
lavag
fluid
report
pneumonia
patient
addit
high
serum
level
correl
presenc
pneumonia
diseas
sever
poor
outcom
earlier
cap
studi
patient
requir
mechan
ventil
septic
shock
show
bacterem
patient
higher
serum
level
compar
cap
patient
unknown
microbi
etiolog
howev
studi
differ
etiolog
patient
sever
acut
ill
requir
mechan
ventil
septic
shock
although
high
serum
level
report
patient
cap
scap
find
signific
differ
concentr
three
etiolog
group
appar
discrep
studi
one
calbo
colleagu
may
due
differ
serum
sampl
time
halfliv
cytokin
halflif
initi
cytokin
respons
rel
short
min
compar
instanc
accord
literatur
may
vari
h
thu
studi
serum
level
may
return
basal
level
time
hospit
admiss
seri
decreas
time
group
studi
children
year
old
hospit
viral
andor
bacteri
communityacquir
pneumonia
patient
identifi
mixeddetect
significantli
higher
serum
level
singl
detect
vitro
studi
shown
compar
singl
pathogen
infect
mix
bacterialvir
coinfect
synergist
increas
express
modul
jakstat
signal
pathway
also
seri
mix
group
highest
statist
signific
valu
worth
notic
confound
factor
may
contribut
observ
differ
cytokin
concentr
cytokin
level
vari
time
mechan
ventil
known
induc
inflammatori
respons
seri
median
time
start
mechan
ventil
first
studi
sampl
collect
h
correl
time
gap
cytokin
level
addit
median
time
sampl
rel
onset
symptom
day
correl
found
time
gap
cytokin
level
studi
show
highest
procalcitonin
among
mg
patient
accord
previou
studi
cap
patient
present
studi
sever
limit
mention
patient
materi
consist
mechan
ventil
scap
patient
singl
center
univers
hospit
limit
gener
result
pneumonia
case
center
howev
thu
far
studi
concern
pattern
cytokin
scap
patient
studi
group
rel
small
especi
respect
viral
pneumonia
thu
confirm
elev
serum
inform
biomark
viral
infect
studi
larger
patient
popul
need
icu
admiss
occur
nighttim
least
hour
delay
obtain
first
studi
sampl
due
lack
inform
consent
laboratori
personnel
therefor
possibl
may
miss
earli
cytokin
find
specif
concern
moreov
result
may
hamper
fact
patient
alreadi
receiv
antibiot
hospit
admiss
find
regard
preliminari
confirm
larger
cohort
patient
first
studi
concern
serum
biomark
profil
adult
mechan
ventil
scap
patient
bacteri
mix
bacterialvir
viral
etiolog
scap
patient
viral
etiolog
higher
level
patient
mix
viral
bacteri
group
higher
pct
compar
etiolog
import
diagnost
biomark
viral
scap
studi
among
larger
patient
cohort
